 | • レポートコード：QY2207C3862 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の新型コロナウイルス感染症小分子薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に新型コロナウイルス感染症小分子薬の世界市場のxxx％を占める「RdRp」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の新型コロナウイルス感染症小分子薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの新型コロナウイルス感染症小分子薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの新型コロナウイルス感染症小分子薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 新型コロナウイルス感染症小分子薬のグローバル主要メーカーには、Shanghai Junshi biosciences、Ascletis Pharma、Merck and Co (MSD)、Pfizer、Shionogiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 新型コロナウイルス感染症小分子薬市場は、種類と用途によって区分されます。世界の新型コロナウイルス感染症小分子薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 RdRp、3CLpro 【用途別セグメント】 病院、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 新型コロナウイルス感染症小分子薬製品概要 - 種類別市場（RdRp、3CLpro） - 用途別市場（病院、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界の新型コロナウイルス感染症小分子薬販売量予測2017-2028 - 世界の新型コロナウイルス感染症小分子薬売上予測2017-2028 - 新型コロナウイルス感染症小分子薬の地域別販売量 - 新型コロナウイルス感染症小分子薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別新型コロナウイルス感染症小分子薬販売量 - 主要メーカー別新型コロナウイルス感染症小分子薬売上 - 主要メーカー別新型コロナウイルス感染症小分子薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（RdRp、3CLpro） - 新型コロナウイルス感染症小分子薬の種類別販売量 - 新型コロナウイルス感染症小分子薬の種類別売上 - 新型コロナウイルス感染症小分子薬の種類別価格 ・用途別市場規模（病院、科学研究） - 新型コロナウイルス感染症小分子薬の用途別販売量 - 新型コロナウイルス感染症小分子薬の用途別売上 - 新型コロナウイルス感染症小分子薬の用途別価格 ・北米市場 - 北米の新型コロナウイルス感染症小分子薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症小分子薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの新型コロナウイルス感染症小分子薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症小分子薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の新型コロナウイルス感染症小分子薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症小分子薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の新型コロナウイルス感染症小分子薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症小分子薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの新型コロナウイルス感染症小分子薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症小分子薬市場規模（トルコ、サウジアラビア） ・企業情報 Shanghai Junshi biosciences、Ascletis Pharma、Merck and Co (MSD)、Pfizer、Shionogi ・産業チェーン及び販売チャネル分析 - 新型コロナウイルス感染症小分子薬の産業チェーン分析 - 新型コロナウイルス感染症小分子薬の原材料 - 新型コロナウイルス感染症小分子薬の生産プロセス - 新型コロナウイルス感染症小分子薬の販売及びマーケティング - 新型コロナウイルス感染症小分子薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 新型コロナウイルス感染症小分子薬の産業動向 - 新型コロナウイルス感染症小分子薬のマーケットドライバー - 新型コロナウイルス感染症小分子薬の課題 - 新型コロナウイルス感染症小分子薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Covid-19 Small Molecule Drugs Market
The global Covid-19 Small Molecule Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, RdRp accounting for % of the Covid-19 Small Molecule Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Covid-19 Small Molecule Drugs market size is valued at US$ million in 2021, while the North America and Europe Covid-19 Small Molecule Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Covid-19 Small Molecule Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Small Molecule Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Small Molecule Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Small Molecule Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Small Molecule Drugs market.
Global Covid-19 Small Molecule Drugs Scope and Market Size
Covid-19 Small Molecule Drugs market is segmented by players, region (country), by Targets and by Application. Players, stakeholders, and other participants in the global Covid-19 Small Molecule Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Targets and by Application for the period 2017-2028.
Segment by Targets
RdRp
3CLpro
Segment by Application
Hospital
Scientific Research
By Company
Shanghai Junshi biosciences
Ascletis Pharma
Merck and Co (MSD)
Pfizer
Shionogi
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Targets
1.2.1 Global Covid-19 Small Molecule Drugs Market Size Growth Rate by Targets, 2017 VS 2021 VS 2028
1.2.2 RdRp
1.2.3 3CLpro
1.3 Market by Application
1.3.1 Global Covid-19 Small Molecule Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Small Molecule Drugs Market Perspective (2017-2028)
2.2 Covid-19 Small Molecule Drugs Growth Trends by Region
2.2.1 Covid-19 Small Molecule Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Covid-19 Small Molecule Drugs Historic Market Size by Region (2017-2022)
2.2.3 Covid-19 Small Molecule Drugs Forecasted Market Size by Region (2023-2028)
2.3 Covid-19 Small Molecule Drugs Market Dynamics
2.3.1 Covid-19 Small Molecule Drugs Industry Trends
2.3.2 Covid-19 Small Molecule Drugs Market Drivers
2.3.3 Covid-19 Small Molecule Drugs Market Challenges
2.3.4 Covid-19 Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Small Molecule Drugs Players by Revenue
3.1.1 Global Top Covid-19 Small Molecule Drugs Players by Revenue (2017-2022)
3.1.2 Global Covid-19 Small Molecule Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Covid-19 Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Small Molecule Drugs Revenue
3.4 Global Covid-19 Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Covid-19 Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Small Molecule Drugs Revenue in 2021
3.5 Covid-19 Small Molecule Drugs Key Players Head office and Area Served
3.6 Key Players Covid-19 Small Molecule Drugs Product Solution and Service
3.7 Date of Enter into Covid-19 Small Molecule Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Small Molecule Drugs Breakdown Data by Targets
4.1 Global Covid-19 Small Molecule Drugs Historic Market Size by Targets (2017-2022)
4.2 Global Covid-19 Small Molecule Drugs Forecasted Market Size by Targets (2023-2028)
5 Covid-19 Small Molecule Drugs Breakdown Data by Application
5.1 Global Covid-19 Small Molecule Drugs Historic Market Size by Application (2017-2022)
5.2 Global Covid-19 Small Molecule Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Covid-19 Small Molecule Drugs Market Size (2017-2028)
6.2 North America Covid-19 Small Molecule Drugs Market Size by Targets
6.2.1 North America Covid-19 Small Molecule Drugs Market Size by Targets (2017-2022)
6.2.2 North America Covid-19 Small Molecule Drugs Market Size by Targets (2023-2028)
6.2.3 North America Covid-19 Small Molecule Drugs Market Share by Targets (2017-2028)
6.3 North America Covid-19 Small Molecule Drugs Market Size by Application
6.3.1 North America Covid-19 Small Molecule Drugs Market Size by Application (2017-2022)
6.3.2 North America Covid-19 Small Molecule Drugs Market Size by Application (2023-2028)
6.3.3 North America Covid-19 Small Molecule Drugs Market Share by Application (2017-2028)
6.4 North America Covid-19 Small Molecule Drugs Market Size by Country
6.4.1 North America Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
6.4.2 North America Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Covid-19 Small Molecule Drugs Market Size (2017-2028)
7.2 Europe Covid-19 Small Molecule Drugs Market Size by Targets
7.2.1 Europe Covid-19 Small Molecule Drugs Market Size by Targets (2017-2022)
7.2.2 Europe Covid-19 Small Molecule Drugs Market Size by Targets (2023-2028)
7.2.3 Europe Covid-19 Small Molecule Drugs Market Share by Targets (2017-2028)
7.3 Europe Covid-19 Small Molecule Drugs Market Size by Application
7.3.1 Europe Covid-19 Small Molecule Drugs Market Size by Application (2017-2022)
7.3.2 Europe Covid-19 Small Molecule Drugs Market Size by Application (2023-2028)
7.3.3 Europe Covid-19 Small Molecule Drugs Market Share by Application (2017-2028)
7.4 Europe Covid-19 Small Molecule Drugs Market Size by Country
7.4.1 Europe Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
7.4.2 Europe Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Small Molecule Drugs Market Size (2017-2028)
8.2 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Targets
8.2.1 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Targets (2017-2022)
8.2.2 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Targets (2023-2028)
8.2.3 Asia-Pacific Covid-19 Small Molecule Drugs Market Share by Targets (2017-2028)
8.3 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Application
8.3.1 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Covid-19 Small Molecule Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region
8.4.1 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Covid-19 Small Molecule Drugs Market Size (2017-2028)
9.2 Latin America Covid-19 Small Molecule Drugs Market Size by Targets
9.2.1 Latin America Covid-19 Small Molecule Drugs Market Size by Targets (2017-2022)
9.2.2 Latin America Covid-19 Small Molecule Drugs Market Size by Targets (2023-2028)
9.2.3 Latin America Covid-19 Small Molecule Drugs Market Share by Targets (2017-2028)
9.3 Latin America Covid-19 Small Molecule Drugs Market Size by Application
9.3.1 Latin America Covid-19 Small Molecule Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Covid-19 Small Molecule Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Covid-19 Small Molecule Drugs Market Share by Application (2017-2028)
9.4 Latin America Covid-19 Small Molecule Drugs Market Size by Country
9.4.1 Latin America Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Small Molecule Drugs Market Size (2017-2028)
10.2 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Targets
10.2.1 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Targets (2017-2022)
10.2.2 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Targets (2023-2028)
10.2.3 Middle East & Africa Covid-19 Small Molecule Drugs Market Share by Targets (2017-2028)
10.3 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Application
10.3.1 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Covid-19 Small Molecule Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country
10.4.1 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Shanghai Junshi biosciences
11.1.1 Shanghai Junshi biosciences Company Details
11.1.2 Shanghai Junshi biosciences Business Overview
11.1.3 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Introduction
11.1.4 Shanghai Junshi biosciences Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.1.5 Shanghai Junshi biosciences Recent Developments
11.2 Ascletis Pharma
11.2.1 Ascletis Pharma Company Details
11.2.2 Ascletis Pharma Business Overview
11.2.3 Ascletis Pharma Covid-19 Small Molecule Drugs Introduction
11.2.4 Ascletis Pharma Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.2.5 Ascletis Pharma Recent Developments
11.3 Merck and Co (MSD)
11.3.1 Merck and Co (MSD) Company Details
11.3.2 Merck and Co (MSD) Business Overview
11.3.3 Merck and Co (MSD) Covid-19 Small Molecule Drugs Introduction
11.3.4 Merck and Co (MSD) Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.3.5 Merck and Co (MSD) Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Covid-19 Small Molecule Drugs Introduction
11.4.4 Pfizer Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 Shionogi
11.5.1 Shionogi Company Details
11.5.2 Shionogi Business Overview
11.5.3 Shionogi Covid-19 Small Molecule Drugs Introduction
11.5.4 Shionogi Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.5.5 Shionogi Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer